The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding .
Notice of Funding Opportunities
Title Announcement Number
Activity Code
Clinical Trials Status Expiration Date
Sort descending
Program Official
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research PAR-22-099 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
05/08/2025
Richard Mazurchuk, Ph.D.
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices RFA-NS-23-003 (RM1 Clinical Trial Optional)
RM1
Clinical Trial Optional
06/10/2025
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices RFA-NS-23-028 (RM1 Clinical Trial Optional)
RM1
Clinical Trial Optional
06/10/2025
Rachel Altshuler, Ph.D.
Discovery and Development of Natural Products for Cancer Interception and Prevention RFA-CA-23-028 (UG3/UH3 Clinical Trial Not Allowed)
UH3, UG3
Clinical Trial Not Allowed
06/14/2025
Altaf Mohammed, Ph.D.
HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices RFA-EB-22-002 (R18 Clinical Trial Not Allowed)
R18
Clinical Trial Not Allowed
06/18/2025
Rachel Altshuler, Ph.D.
HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery NOT-NS-22-095
06/25/2025
Rachel Altshuler, Ph.D.
Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials NOT-CA-23-071
07/01/2025
Ellen Richmond, M.S., G.N.P.-B.C.
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers NOT-CA-23-004
07/02/2025
Matthew Young, Ph.D.
NCI Clinical and Translational Exploratory/Developmental Studies PAR-22-216 (R21 Clinical Trial Optional)
R21
Clinical Trial Optional
07/02/2025
Marjorie Perloff, M.D.
Biology of Bladder Cancer PAR-22-219 (R21 Clinical Trial Optional)
R21
Clinical Trial Optional
09/08/2025
